Landos Biopharma Announces First Patient Dosed in a Phase 2 Study of Omilancor for Moderate-to-Severe Crohn’s Disease
May 06, 2021 16:01 ET
|
Landos Biopharma, Inc.
Company’s second omilancor program entering a Phase 2 study with plans to pursue at least five autoimmune indications Topline results are expected in the second quarter of 2022 BLACKSBURG, Va., May ...
Celyad Oncology Announces First Quarter 2021 Financial Results and Recent Business Highlights
May 06, 2021 16:01 ET
|
Celyad Oncology SA
Enrollment continues in second dose cohort of Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate, CYAD-211, for relapsed/refractory multiple myeloma (r/r MM);...
Chicken Soup for the Soul Entertainment’s Free Streaming Service Crackle Premieres Season Two of Ashton Kutcher Executive Produced Series ‘Going From Broke’ on May 20
May 06, 2021 16:01 ET
|
Chicken Soup for the Soul Entertainment, Inc.
COS COB, Conn., May 06, 2021 (GLOBE NEWSWIRE) -- Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD)...
Oyster Point Pharma Reports First Quarter 2021 Financial Results and Recent Business Highlights
May 06, 2021 16:01 ET
|
Oyster Point Pharma, Inc.
PDUFA Target Action Date for OC-01 (varenicline) Nasal Spray is October 17, 2021Planned U.S. Launch of OC-01 (varenicline) Nasal Spray in Q4 2021, if approved by the FDAOLYMPIA Phase 2 Study on Track,...
Spero Therapeutics Announces First Quarter 2021 Operating Results and Provides Business Update
May 06, 2021 16:01 ET
|
Spero Therapeutics, Inc.
Tebipenem HBr remains on track for NDA submission in the second half of 2021 Conference call and live webcast at 4:30 p.m. ET today CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Spero...
First Quantum Minerals Announces Voting Results For The Election Of Directors
May 06, 2021 16:01 ET
|
First Quantum Minerals Ltd.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX:FM) announced that the nominees listed in the Management Information Circular for the...
Bionano Genomics to Report First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 13, 2021
May 06, 2021 16:01 ET
|
Bionano Genomics
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, May 13, 2021 at 4:30 p.m. Eastern...
Y-mAbs Announces First Quarter Financial Results and Recent Corporate Developments
May 06, 2021 16:01 ET
|
Y-mAbs Therapeutics, Inc
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and...
Zogenix Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 06, 2021 16:01 ET
|
Zogenix, Inc
Continued positive momentum for U.S. launch of FINTEPLA® (fenfluramine) oral solution in Dravet syndrome, with total net product sales of $12.3 million and total revenue of $13.7 million in the first...
CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer
May 06, 2021 16:01 ET
|
CRISPR Therapeutics AG
-Collaboration brings together breakthrough gene editing technology and leading natural killer (NK) cell and T cell discovery, development, and manufacturing capabilities- -Companies to co-develop...
- May 05, 2024 11:55 ET Secrets to Trading 101 Unveils In-Depth Guides on Forex and Crypto Trading
- May 05, 2024 10:30 ET Boyu to Showcase Cutting-Edge SPC Flooring Production Lines at NPE2024